Thailand has delayed use of the Oxford/AstraZeneca vaccine after several European countries temporarily suspended the jabs following reports of blood clots in some people. Instead, health officials held a news conference to explain the delay was based on the decision made by Denmark, Austria and others, as a precaution. The Danish health authority said on Thursday it has no evidence the vaccine was responsible for blood clots. Read MoreOther experts pointed out that of the millions of AstraZeneca vaccine jabs administered elsewhere, including in the UK, there have been no reported cases of the vaccine causing blood clots or related problems. Thailand started its vaccination drive last month with an initial 200,000 doses of China’s Sinovac and 117,000 doses of AstraZeneca, which is also being manufactured locally.

Source: Irish Independent March 12, 2021 08:01 UTC